Gotham Asset Management LLC Invests $1.03 Million in Option Care Health, Inc. (NASDAQ:OPCH)

Gotham Asset Management LLC purchased a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 44,419 shares of the company's stock, valued at approximately $1,031,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Wellington Management Group LLP increased its holdings in Option Care Health by 84.6% in the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after buying an additional 8,400,208 shares in the last quarter. Norges Bank bought a new position in shares of Option Care Health during the 4th quarter valued at approximately $60,219,000. Freestone Grove Partners LP bought a new position in Option Care Health in the 4th quarter valued at $17,487,000. Dimensional Fund Advisors LP grew its position in Option Care Health by 17.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock valued at $92,518,000 after acquiring an additional 591,042 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its holdings in shares of Option Care Health by 31.1% in the 4th quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company's stock worth $49,310,000 after buying an additional 503,840 shares during the period. Hedge funds and other institutional investors own 98.05% of the company's stock.

Option Care Health Trading Down 1.9%

Shares of NASDAQ OPCH traded down $0.62 during trading on Friday, reaching $31.41. The stock had a trading volume of 836,498 shares, compared to its average volume of 1,858,964. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The business's 50-day moving average price is $32.99 and its 200-day moving average price is $29.30. The company has a market cap of $5.14 billion, a P/E ratio of 26.39, a PEG ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. Option Care Health's revenue for the quarter was up 16.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.26 EPS. On average, equities research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Insider Activity

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.80% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.64% of the company's stock.

Analysts Set New Price Targets

OPCH has been the subject of a number of research analyst reports. JPMorgan Chase & Co. increased their price target on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and lifted their price target for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 price target on shares of Option Care Health in a research note on Tuesday, April 22nd. Barrington Research reaffirmed an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research note on Wednesday, April 30th. Finally, UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $35.50.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.